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doi:10.1016/j.jtcvs.2006.03.056ackground: Structural valve deterioration is the major cause of bioprosthetic valve
ailure. Because of the unique design features and anti-calcification treatment of the
reestyle (Medtronic Inc, Minneapolis, Minn) stentless bioprosthesis, development
f structural valve deterioration may differ in comparison with other bioprosthetic
alves. This study evaluates the mechanisms and clinical presentation of structural
alve deterioration in the Freestyle stentless bioprosthesis.
ethods: Between January 1993 and August 2005, 608 patients underwent aortic
alve replacement with a Freestyle stentless bioprosthesis. The implantation tech-
ique was subcoronary in 475 patients and a root replacement in 133 patients. Mean
verall follow-up was 5.6  3.4 years. Follow-up was complete in all patients.
linical and echocardiographic follow-ups were conducted prospectively.
esults: Freedom from structural valve deterioration was 95.8% at 10 years. Twelve
atients showed evidence of structural valve deterioration and underwent reopera-
ion for aortic regurgitation (n  10) or aortic stenosis (n  2). The mean age of
atients with structural valve deterioration was significantly lower than patients
ithout structural valve deterioration (62.6  8.2 years vs 68.6  8.3 years, P 
02). The median time between implantation and explantation was 8.7 years
range: 1.9-13.3 years). Eleven structural valve deteriorations occurred after
ubcoronary implantation, and 1 structural valve deterioration occurred after
oot implantation (P  .4). The mechanisms of structural valve deterioration
ere leaflet tears in 10 patients (6 in the left coronary cusp and 4 in the right
oronary cusp), severe valve calcification in 1 patient, and cusp fibrosis in 1
atient. The interval between onset of symptoms and reoperation was acute or
ubacute in 10 patients.
onclusion: At 10 years, the Freestyle stentless bioprosthesis shows excellent
reedom from structural valve deterioration. Structural valve deterioration in the
reestyle stentless bioprosthesis relates to leaflet tear with minimal calcification in
he majority of cases. Because of the fast onset of symptoms with leaflet tear,
atients with a Freestyle stentless bioprosthesis should be informed of the prefer-
ntial mode of failure and time-frame of symptoms.
eplacement of a diseased aortic valve with a stented bioprosthesis is a
well-established therapeutic approach. However, prosthesis degeneration
ultimately limits the use of these devices, especially in younger patients.
uring the past decade, stentless aortic bioprostheses have been used for the
eplacement of diseased aortic valves and root pathologies. Excellent hemodynamic
erformance with early regression of left ventricular hypertrophy has been reported
fter implantation of stentless aortic valves.1-3 The Freestyle (Medtronic Inc, Mi
eapolis, Minn) aortic root stentless bioprosthesis (FSB) may be implanted using
ifferent techniques, mainly in a subcoronary or root configuration. Since the first
uman implants in 1992, issues regarding durability have yet to be addressed.
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A
CDecause of the unique design features of stentless valves,
echanisms and rate of failure may differ compared with
arious stented prostheses. Furthermore, mechanisms of
ailure may differ according to the implantation technique.
he purpose of the present study is to describe the presen-
ation, rate, and mechanisms of structural valve deteriora-
ion (SVD) in the FSB.
atients and Methods
etween January 1993 and August 2005, 3428 prosthetic aortic
alves were implanted in patients at the Québec Heart Institute,
uébec City, Canada. Of these replacements, 608 were performed
ith an FSB. Table 1 summarizes the clinical and oper
haracteristics of the FSB cohort. During the same time-frame,
3 stented bioprostheses were explanted. Of these, 48 valves
ere explanted for SVD 10.9  3.9 years after the initial
rocedure; prostheses were macroscopically calcified in 39.6%
f cases with aortic regurgitation leading to reoperation in
4.3% of cases.
Among the 608 patients with an FSB, the implant technique
as a subcoronary position in 475 patients (78.1%) and a root
echnique in 133 patients (21.9%). The operative techniques have
een described.4 The subcoronary implantation technique w
erformed with preservation of the noncoronary sinus.
All patients were followed annually in a dedicated valve clinic.
ransthoracic echocardiograms were obtained every other year.
ollow-up was complete in all patients. Mean overall follow-up was
.6  3.4 years (range 0.2-12.2 years) and 6.0  3.3 and 4.0  3.2
ears for patients with subcoronary and root implantation configura-
ions, respectively.
In accordance with the American Association for Thoracic
urgery and the Society of Thoracic Surgeons Committee for
tandardizing prosthetic heart valve morbidity,5 SVD was de-
ned as any change in function of an FSB resulting from any
alve abnormality exclusive of infection or thrombosis.
ata Analysis
he primary end point was the presence of significant SVD of
he FSB diagnosed on successive echocardiograms or at reop-
ration. Continuous data are presented as mean  standard
eviation. Percentages were determined for categoric variables.
ontinuous data were compared using a nonpaired Student
test, and categoric variables were compared using a chi-square
nalysis. By using univariate and multivariate analyses, peri-
perative risk factors age 65 years or 65 years, sex, pres-
nce of high blood pressure, and technique of implantation
subcoronary vs root) were evaluated to determine whether any
ingle variable influenced the incidence of SVD. Time-related
nalysis was performed by the Kaplan-Meier method. A log-
Abbreviations and Acronyms
FSB  Freestyle aortic root stentless bioprosthesis
SVD structural valve deteriorationank test was used to test for differences in freedom from SVD. w
02 The Journal of Thoracic and Cardiovascular Surgery ● Auguctuarial freedom from SVD was also stratified according to
mplantation technique and age.
esults
linical and Operative Profile
wenty-seven patients (4.4%) within the FSB cohort re-
uired reoperation, 12 (44%) of whom had an SVD diag-
osis. Fifteen other patients had their FSB explanted during
he same period: early (24 hours) in 4 patients because of
echnical issues and late (3 months) in 11 patients because
f severe mismatch (3 patients), endocarditis (2 patients),
aravalvular leak (3 patients), partial dehiscence of root
eplacement (2 patients), and central regurgitation caused
y sinotubular junction dilatation (1 patient). All patients
ith significant clinical or echocardiographic signs of SVD
nderwent reoperation. The mean age of patients with SVD
as significantly lower than that of other patients (62.6 
.2 years vs 68.6  8.3 years, P  .02).
Table 2 depicts patient demographics and operative 
t the initial operation for the 12 patients with SVD. Eleven
atients with a subcoronary implant and 1 patient with total
oot implantation required reoperation for SVD. However,
hen considering the overall incidence of SVD according to
he implantation technique, SVD was diagnosed in 2.3% of
atients with a subcoronary implant and in 0.7% of patients
ABLE 1. Clinical and operative characteristics of the 608
atients with Freestyle (Medtronic Inc, Minneapolis, Minn)
ortic valve bioprotheses
n %
ex
Male 334 54.9
Female 274 45.1
ge (y) 68 8.3
ause
Senile calcification 324 53.3
Bicuspid 152 25.0
Rheumatic 38 6.2
Myxomatous 31 5.1
Prosthetic dysfunction 30 4.9
Endocarditis 9 1.5
Other 24 3.8
alve size distribution
19 mm 17 2.8
21 mm 92 15.1
23 mm 153 25.2
25 mm 169 27.8
27 mm 149 24.5
29 mm 28 4.6
perative technique
Subcoronary 475 78.1
Root 133 21.9ith a root implantation (P  .4). The mean interval time
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A
CDetween FSB implantation and explantation for SVD was
.8  3.3 years (median: 8.7 years, range 1.9-13.3 years).
n 3 patients, the interval between the initial procedure
nd the reoperation was within 5 years. One patient
resented with a rapidly evolving calcific stenosis. In the
ther 2 patients, leaflet tears supervened on valves with
o or minimal aortic regurgitation on previous echocar-
iography assessment.
Table 3 depicts clinical and operative variables of
ients with SVD at reoperation. All patients presented dys-
nea either secondary to severe aortic regurgitation in 10
ases or aortic stenosis in 2 cases. The interval between
nset of symptoms and reoperation was acute (1 month)
r subacute (1-3 months) in 10 patients, and chronic (3
onths) in 2 patients.
ABLE 2. Demographics and operative data at the initial o
D Sex Age at initial implant Indication
1 F 48 AR
2 M 55 AS
3 M 62 AS
4 M 68 AS
5 M 76 AS
6 F 68 AS
7 M 50 AR
8 M 67 AS
9 M 67 AS
0 F 60 AS
1 M 57 AS
2 M 65 AS
R, Aortic regurgitation; AS, aortic stenosis; FSB, Freestyle (Medtronic Inc
ypass grafting.
ABLE 3. Clinical presentation and operative data perform
D
Clinical
presentation Indication
Implant duration
(y) Operative findings
1 A AR 12 Tear
2 S-A AR 8, 8 Tear
3 A AR 6, 9 Tear
4 S-A AR 8, 7 Tear
5 A AR 3, 3 Tear
6 S-A AR 8, 6 Tear
7 S-A AR 1, 9 Tear
8 A AR 13, 2 Tear
9 S-A AR 8, 3 Tear
0 C AS 3, 5 Stenosis
1 C AS 10, 2 Stenosis
2 S-A AR 11, 6 Tear
, Acute (1 mo); S-A, subacute (1-3 mo); C, chronic (3 months); AR, aort
ortic valve replacement; MVR, mitral valve replacement; CABG, coronary arte
The Journal of Thoraciceoperation and Pathologic Findings
en patients with severe aortic regurgitation were found to
ave tears in 1 aortic cusp: 6 in the left coronary leaflet and
in the right coronary leaflet. Tears were located at the base
n  4) or in the vicinity of the commissure (n  6).
acroscopic calcification was absent in the 10 patients with
ortic regurgitation caused by leaflet tear. In the 2 patients
ith aortic stenosis, severe leaflet calcification was found in
patient, and leaflet fibrosis with mild to moderate calcifi-
ation was found in 1 patient. On histology, all leaflets
howed different degrees of degeneration with the presence
f fibrotic patches. Radiographic reports of explanted valve
pecimens were obtained through the Medtronic Heart
alve Laboratory (Santa Ana, Calif) in 10 patients. Reports
epicted severe calcification in the 2 patients with aortic
tion in patients with structural valve deterioration
SB size (mm) Type of procedure Concomitant surgery
25 Root
27 Subcoronary
25 Subcoronary CABG 1
27 Subcoronary
27 Subcoronary CABG 1
21 Subcoronary
27 Subcoronary
25 Subcoronary CABG 1
27 Subcoronary
25 Subcoronary
25 Subcoronary CABG 1
25 Subcoronary CABG 2
neapolis, Minn) aortic root stentless bioprosthesis; CABG, coronary artery
uring reoperation for structural valve deterioration
Calcification AVR valve type Size
Concomitant
surgery
sent St Jude (St Jude Medical,
St Paul, Minn)
21
ace St Jude 23 MVR
sent CE pericardial 21
ace Magna 23 CABG 1
sent Mosaic 29
ace Magna 19 CABG 1
sent St Jude 25
ace CE pericardial 21
ace Magna 21 CABG 2
vere Magna 19
vere fibrosis Magna 19 CABG 1
ace Mosaic 23 CABG 2
urgitation; AS, aortic stenosis; CE, Carpentier-Edwards (Irvine, Calif); AVR,pera
F
, Mined d
Ab
Tr
Ab
Tr
Ab
Tr
Ab
Tr
Tr
Se
Se
Tr
ic reg
ry bypass grafting.
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A
CDtenosis, minimal calcification in at least 1 of the leaflets in
patients, and no calcification in 2 patients. Analysis could
ot take into account the anatomic position of the leaflet.
ne patient died perioperatively of a pulmonary embolism
n the eighth postoperative day.
reedom from Reoperation for Structural
alve Deterioration
igures 1 and 2 show the echocardiographic follow-u
erms of mean gradient and aortic regurgitation grade for the
hole FSB cohort. Actuarial freedom from reoperation for
VD in the FSB cohort was 95.8% at 10 years (Figu
ctuarial freedom from SVD stratified according to age
65 years and 65 years old) was 96.1% and 95.3%,
espectively. Univariate analysis did not identify gender,
ystemic hypertension, or chronic renal failure as risk fac-
ors for SVD.
iscussion
he FSB has been proposed to provide enhanced physio-
ogic hemodynamic performance and potentially greater04 The Journal of Thoracic and Cardiovascular Surgery ● Augu).
urability because of lower mechanical stress on the leaflets.
he present study confirms the excellent midterm durability
f the FSB. The longitudinal echocardiographic data further
upport the stability of the FSB performance at midterm.
he current data compare favorably with the freedom from
tructural valve deterioration observed with currently avail-
ble stented bioprostheses.6-8 Bach and colleagues,9 in a
ulticenter study, reported a similar freedom from struc-
ural valve deterioration in patients with an FSB.
Structural valve deterioration of bioprosthetic valves is a
omplex process that remains to be fully understood. Calcifi-
ation is the most frequent factor contributing to the failure of
ontemporary glutaraldehyde-pretreated porcine aortic valve
ioprostheses. Inflammatory and immune responses have been
mplicated in the calcification process of bioprosthetic
alves.10,11 To lessen the calcium deposits on glutaraldehy
retreated bioprostheses, several types of tissue anti-mineral-
zation treatments have been proposed. The FSB is a porcine
ortic root pretreated with alpha-amino oleic acid, an anti-
alcification agent shown to abolish porcine leaflet calcifica-
Figure 1. Mean gradient at echocardiographic
follow-up for the 608 patients with Freestyle
(Medtronic Inc, Minneapolis, Minn) valves.
Figure 2. Longitudinal assessment of the echo-
cardiographic aortic regurgitation grade for the
608 patients with Freestyle valves. AI, Aortic
insufficiency.st 2006
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A
CDion in animal models.12 The current data support the an
alcification properties of the FSB valve because only 1 valve
howed significant macroscopic calcium deposits. Mecha-
isms of valve deterioration were related to leaflet tear in 10
atients. Such a mechanism may suggest a “wear and tear”
athophysiology to explain the tears. The “wear and tear”
henomenon leading to valve failure has been reported with
tented bioprostheses such as the Ionescu-Shiley bovine peri-
ardial bioprosthesis13 and is further supported by the s-
nalysis of our non-FSB cohort requiring reoperation for SVD.
recent multicenter study also suggested leaflet tear as the
echanism of valve failure in patients with an FSB.9 Within
he present study, the “wear and tear” hypothesis is substanti-
ted by the histology of the explanted leaflets, which show
ariable amounts of degeneration of the extracellular matrix
ith minimal calcification. The leaflet tears were located on
he right and left cusps, thus sparing the noncoronary cusp.
uch a finding may imply an uneven stress distribution on the
eaflets with premature degeneration of the overpressurized
eaflets leading to leaflet tear. Because our preferred method of
mplantation for the subcoronary position includes preserva-
ion of the noncoronary sinus, one may speculate that suture
lacement in the right and left sinuses may confer uneven
tress zones on the right and left leaflets leading to leaflet tear.
nfortunately, our histology examination did not differentiate
etween the leaflets’ location, which could have further vali-
ated this hypothesis. On the other hand, the root implantation
echnique may lessen the uneven stress distribution secondary
o sinus suture placement. Although no significant difference
n the incidence of SVD was observed compared with the
ubcoronary technique, the only leaflet tear encountered in the
oot implantation group supervened more than 13 years post-
peratively. Increasing the number of structural valve failures
ith a longer follow-up will establish whether differences inncidence of SVD may be linked to the implantation technique.
The Journal of ThoracicWhen assessing the clinical characteristics of patients sus-
aining SVD, our study shows a majority of patients with rapid
nset of dyspnea as suggested by the interval of less than 3
onths between symptom onset and reoperation. Such a clin-
cal presentation suggests a rapid transition between a normal
unctioning valve and severe valve regurgitation caused by
eaflet tear. This rapid transition is further supported by the
tability of the aortic regurgitation in the FSB cohort at
idterm.
onclusion
he FSB shows excellent freedom from structural valve dys-
unction at 10 years. Most SVD in patients with an FSB is
inked to leaflet tear with minimal cusp calcification. Further
nvestigations are required to thoroughly understand mecha-
isms implicated in SVD in patients with an FSB, such as the
mpact of the implantation technique. Finally, physicians
hould inform patients with an FSB on its preferential failure
ode and the time-frame of symptoms associated with SVD in
atients with an FSB.
The authors thank Mrs. Brigitte Dionne for assistance in data
nalysis and Mrs Martine Fleury for technical support.
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